Cancer Care by 2035: Early Detection and Continuous Improvement

LSU LCMC Health Cancer Center Expands Clinical Trials Office “Clinical trials are how we turn today’s discoveries into tomorrow’s standard of care,” said Dr. Lucio Miele, Director of the LSU LCMC Health Cancer Center. "This is a cornerstone of our mission to build a cancer center that delivers world-class care, drives discovery, and transforms outcomes for our state.” Full story here: https://lnkd.in/g359C7Xu #BizNewOrleans

The Fred & Pamela Buffett Cancer Center, Nebraska’s only National Cancer Institute (NCI)-designated cancer center has launched two new data visualization tools to help communities in Nebraska better understand cancer burden and support local prevention and screening efforts. https://buff.ly/hNYaJm8 #MED #BuffetCancerCenter

This National Cancer Research Month, we’re proud to uplift the scientists, providers, and advocates leading the way in discovery! The 2024 Texas Cancer Plan highlights the importance of investing in innovative cancer research to improve prevention, diagnosis, treatment, and survivorship across Texas. We continue to support efforts that turn research into real, world impact.  Learn more about the Plan: www.texascancerplan.org #TexasCancerPlan #2024TexasCancerPlan #CancerResearch #PublicHealth #HealthInnovation

📢 Clinical trial now enrolling! Jennifer Ligibel, MD (Dana-Farber Cancer Institute) and Kathryn Schmitz, PhD (UPMC Hillman Cancer Center) are leading Alliance A222302, a study exploring the feasibility of a telehealth exercise program for cancer patients. The goal? To help reduce fatigue and disability and improve quality of life. Learn more about the trial here: https://lnkd.in/gK99ZsWc #NCI #NCTN #CancerResearch #ClinicalTrials

May 20 marks International #ClinicalTrialsDay and we want to recognise people impacted by cancer, health practitioners and researchers committed to clinical research. Their dedication helps us find new ways to treat cancer. Cancer clinical trials focus on ways to: 👉 Treat cancer 👉 Find and diagnose cancer 👉 Prevent cancer 👉 Make you feel better & improve wellbeing Find out more on the Cancer Institute NSW website: https://ow.ly/mO0r50Z1t1b

May 20 marks International #ClinicalTrialsDay and we want to recognise people impacted by cancer, health practitioners and researchers committed to clinical research. Their dedication helps us find new ways to treat cancer. Cancer clinical trials focus on ways to: 👉 Treat cancer 👉 Find and diagnose cancer 👉 Prevent cancer 👉 Make you feel better & improve wellbeing Find out more on the Cancer Institute NSW website: https://ow.ly/3Xrx50Z1t1a

AOA Dx presented two new studies at the American Association for Cancer Research (AACR) Annual Meeting, demonstrating significant advancement toward a non-invasive, blood-based test for the early detection of ovarian cancer in women experiencing signs and symptoms. They are actively preparing for an early access program of the AKRIVIS GD™ Test System, with more data to share soon. Read more in CLP Magazine: https://lnkd.in/gKtD75sa and stay tuned! cc: Oriana Papin-Zoghbi Anna Milik Jeter Abigail McElhinny Alexander Fisher Emma Martin

May 20 marks International #ClinicalTrialsDay and we want to recognise people impacted by cancer, health practitioners and researchers committed to clinical research. Their dedication helps us find new ways to treat cancer. Cancer clinical trials focus on ways to: 👉 Treat cancer 👉 Find and diagnose cancer 👉 Prevent cancer 👉 Make you feel better & improve wellbeing Find out more on the Cancer Institute NSW website: https://ow.ly/9iqL50Z1t17

Partner Gary Gustavsen has a newly published #ASCO26 abstract focusing on current limitations in US cancer screening rate data and opportunities to address gaps in this ecosystem to drive improvements in patient outcomes.  #Oncology #PrecisionMedicine Arushi Agarwal, Owen Fahey, MPH, Elissa Mitchell Quinn, Jody Hoyos, MHA, Chyke Doubeni, Daryl Pritchard, AstraZeneca, Prevent Cancer Foundation, The Ohio State University, Personalized Medicine Coalition

Partner Gary Gustavsen has a newly published #ASCO26 abstract focusing on current limitations in US cancer screening rate data and opportunities to address gaps in this ecosystem to drive improvements in patient outcomes.  #Oncology #PrecisionMedicine Arushi Agarwal, Owen Fahey, MPH, Elissa Mitchell Quinn, Jody Hoyos, MHA, Chyke Doubeni, Daryl Pritchard, AstraZeneca, Prevent Cancer Foundation, The Ohio State University, Personalized Medicine Coalition